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 2 
Abstract  26 
Macrophages in the lung detect and respond to influenza A virus (IAV), determining the nature of the 27 
immune response.  Using terminal depth 5’-RNA sequencing (CAGE) we quantified transcriptional 28 
activity of both host and pathogen over a 24-hour timecourse of IAV infection in primary human 29 
monocyte-derived macrophages (MDM). This method allowed us to observe heterogenous host 30 
sequences incorporated into IAV mRNA, “snatched” 5’ RNA caps, and corresponding RNA sequences 31 
from host RNAs. In order to determine whether cap-snatching is random or exhibits a bias , we 32 
systematically compared host sequences incorporated into viral mRNA (“snatched”) against a 33 
complete survey of all background host RNA in the same cells, at the same time. Using a 34 
computational strategy designed to eliminate sources of bias due to read length, sequencing depth, 35 
multi-mapping, we were able to quantify over-representation of host RNA features among the 36 
sequences that were snatched by IAV.  We demonstrate biased snatching of numerous host RNAs, 37 
particularly snRNAs, and avoidance of host transcripts encoding host ribosomal proteins, which are 38 
required by IAV for replication.  We then used a systems approach to describe the transcriptional 39 
landscape of the host response to IAV, observing many new features, including a failure of IAV-40 
treated MDMs to induce feedback inhibitors of inflammation, seen in response to other treatments. 41 
Importance 42 
Infection with influenza A virus (IAV) infection is responsible for an estimated 500,000 deaths and up 43 
to 5 million cases of severe respiratory illness each year. In this study we looked at human primary 44 
immune cells, macrophages, infected with influenza A. Our method allows us to look at both the host 45 
and the virus in parallel. We used this data to explore a process known as 'cap-snatching', where 46 
influenza A snatches a short nucleotide sequence from capped host RNA. This process was believed 47 
to be random. We demonstrate biased snatching of numerous host RNAs, including those associated 48 
with snRNA transcription, and avoidance of host transcripts encoding host ribosomal proteins, which 49 
are required by IAV for replication. We then describe the transcriptional landscape of the host 50 
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 3 
response to IAV, observing new features, including a failure of IAV-treated MDMs to induce feedback 51 
inhibitors of inflammation, seen in response to other treatments. 52 
  53 
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 4 
Introduction 54 
Infection with influenza A virus (IAV) infection is responsible for an estimated 500,000 deaths and up 55 
to 5 million cases of severe respiratory illness each year (WHO) (1).  The abundant macrophages of 56 
the airway and lung interstitium detect and respond to the virus, determining both the nature and 57 
the magnitude of the innate and acquired immune response (2), and contribute to systemic 58 
inflammatory cytokine production in severe influenza (3).   59 
As an obligate intracellular parasite, IAV is reliant on host cellular machinery for replication. The IAV 60 
genome comprises 8 negative-sense RNA segments that are transcribed and replicated in the nucleus 61 
of the host cell.  In order to co-opt host translational machinery, and to evade detection of non-self 62 
RNAs by host cells, IAV “snatches” 5’ RNA caps from host RNAs. The IAV polymerase binds directly to 63 
the 5’ 7-methylguanylate cap of a nascent host RNA and cleaves it roughly 10-14 nucleotides 64 
downstream. The snatched “leader” sequence is employed as a primer for efficient transcription of 65 
the viral mRNA (4) and subsequently, the host cap facilitates translation of viral mRNAs by host 66 
ribosomes.  Previous large-scale studies of this process (5–8) have produced evidence that host-67 
derived RNA caps are frequently snatched from non-coding RNAs, particularly small nuclear RNAs 68 
(snRNAs), due to their high abundance in infected cells.  This has led to the conclusion that cap-69 
snatching is not a selective process – that is, that capped host RNAs are snatched at random (8, 9).   70 
Previous RNA-seq studies have detected snatched leaders, but have been unable observe the 71 
complete pool of unsnatched sequences, because of limited sequencing depth and resolution at the 72 
5’ end, both of which are necessary to accurately quantify the background distribution of each host 73 
transcript.  74 
To overcome these limitations, we utilised single molecule, terminal-depth cap analysis of gene 75 
expression (CAGE) to sequence all capped RNA from primary monocyte-derived macrophages 76 
(MDMs) from 4 human donors in vitro at 4 time points over the course of a 24 hour, productive 77 
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 5 
infection with IAV. The CAGE RNA sequencing method captures both host and virus-derived 78 
transcripts and, importantly, does not require a PCR amplification step, thus eliminating PCR bias.   79 
By comparing the sequences of the snatched population to the sequences of the total capped RNA 80 
background, we observed biases in the snatching of transcripts encoding spliceosome components 81 
and avoidance of transcripts encoding host ribosomes.   82 
This methodology allowed us to observe the transcriptional response to IAV infection over time in 83 
unprecedented molecular detail.  We previously used CAGE to quantify transcript expression, 84 
promoter and enhancer activity in human MDM and produced a detailed time course profiling their 85 
response to bacterial lipopolysaccharide (LPS) (10).  In a comprehensive analysis of the host 86 
macrophage transcriptome during IAV exposure, we used a similar systems approach, using co-87 
expression to identify key biological processes (11, 12), and compare the response of MDMs to both 88 
IAV and LPS, revealing IAV-specific features of the host response.   89 
 90 
 91 
  92 
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 6 
Results  93 
Transcriptional activity of IAV in human MDMs  94 
To observe IAV transcriptional dynamics in human MDMs in vitro, we infected MDMs from four 95 
different donors with influenza A/Udorn/72 (H3N2; hereafter, IAV) at a multiplicity of infection (MOI) 96 
of 5 (Figure 1 A). RNA libraries were prepared from cells at 0, 2, 7, and 24 hours post-infection and 97 
from two uninfected-infected samples at 0 and 24 hours.  Libraries were sequenced using HeliScope 98 
CAGE as previously described (11, 13).  A minority of cells were positive for viral antigen (IAV 99 
nucleoprotein) by immunofluorescence after 2 hours and the large majority after 7 hours (Figure 1 B), 100 
suggesting that viral mRNA molecules were being transcribed and translated. We confirmed a 101 
previous report (14) that IAV-infected MDM cells release infectious virus (Figure 1 C), albeit at 102 
approximately 10-fold lower levels compared to published results for permissive cancer cell lines (15, 103 
16), and with little evidence of cell death up to 7 hours (Figure 1 D).  104 
IAV mRNAs contain a conserved 12-base long 5’-adjacent non-coding region present in all 8 segments 105 
('AGCAAAAGCAGG’) derived from template-dependent transcription of the viral promoter (9).  This 106 
sequence was used to identify viral transcripts.  Similar to results seen elsewhere (7, 17, 18), the A at 107 
the 5’ end of the IAV promoter was not always present and so sequences which contained the 11 108 
nucleotide sequence ‘GCAAAAGCAGG’ (IAV promoter) were brought forward for analysis (Figure 1 E).   109 
Most (74%) of the leader sequences, those preceding the promoter, were between 10 and 14 110 
nucleotides long (Figure 1 F).  Published studies of IAV-infected A549 cells have reported that, within 111 
8 hours post-exposure, >50% of total cellular mRNA was viral (19).  In contrast, IAV RNA constituted a 112 
relatively small proportion (4 -11%) of total capped RNA in MDMs, even at the peak of viral 113 
replication (Figure 1 G). 114 
The relative proportion of IAV mRNA arising from each viral segment was also consistent across the 4 115 
donors at each time point (Figure 2 A), consistent with previous evidence that transcription of each 116 
segment is a highly controlled process (20).  By 24 hours, the pattern was less defined, which may be 117 
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 7 
a consequence of mRNA decay and/or potential reinfection of the minor fraction of cells not infected 118 
at time 0.  119 
Potential alternative splice variants in IAV 120 
Spicing has been observed in segments 7 and 8 of IAV. In particular, segment 7 contains the splice 121 
donor site for the mRNA3/M3 transcript, which is found at the end of the promoter sequence 122 
(27) . Over 400,000 reads contained the IAV promoter sequence and a leader sequence, but did not 123 
originate from the genome sequence proximal to the promoter in any of the 8 segments. The leader 124 
and promoter sequences were removed and the sequences aligned throughout the Udorn genome. 125 
In order to quantify RNA expression at these loci, we summed the weighted abundances of reads 126 
originating at the same position. This revealed 6,902 putative capped IAV RNA sequences from the 127 
IAV genome, including the known splice variant of segment 7, the mRNA3 transcript (Figure 2 B). The 128 
alignments observed (Table S1) are likely to include previously unidentified splice variants. 129 
However, in a systematic search, no putative IAV splice variant RNA was preceded by a canonical 130 
major spliceosome acceptor site, apart from the mRNA3 transcript. It is possible these represent 131 
variants that are expressed in such low amounts they are not detectable by other means, for example 132 
northern blot or radioactive primer extension. It is of interest to determine if these putative mRNAs 133 
are true transcription products and if their transcription and translation contributes to viral 134 
pathogenesis. 135 
Characterisation of host leader sequences incorporated into viral capped RNA 136 
We identified 4,575,918 unique leader sequences, heterogeneous in both sequence and length, 137 
snatched from the host and incorporated into viral mRNA. Contrary to previous reports (5, 8), we 138 
observed no difference in leader lengths between different viral segments.  18.8% (859,789) of leader 139 
sequences appeared more than once and 1.5% (69,443) appeared ten times or more across all 140 
samples, indicating the presence of a highly snatched population. 141 
 o
n
 M
arch 12, 2020 at UNIVERSITY O
F EDINBURG
H
http://jvi.asm.org/
D
ow
nloaded from
 
 8 
We sought to determine whether there was over-representation of particular sequences, host 142 
transcripts, or biological pathways in the population of leader sequences compared to the 143 
background population of CAGE reads.  In order to eliminate the risk of bias due to the different rates 144 
of successful mapping for sequences of different lengths, we restricted our analysis to the first 10 145 
bases of every CAGE tag (10mers), including both IAV and host sequences. The number of times a 146 
10mer was followed by the IAV promoter, i.e. incorporated into viral mRNA (“snatched”), was 147 
compared to the number of times a 10mer was not followed by an IAV promoter (“unsnatched”) 148 
using Fisher’s Exact test (FDR <0.05) at each time point.  Of 29,195 10mers meeting our minimum 149 
count threshold of 1000 reads, we assigned a host transcript identity to 12,992 (44.5%). The 150 
remainder are a mixture of alternative host promoters, lncRNAs, eRNAs and other RNA species (21).  151 
Within these named 10mers, 6,353 mapped ambiguously to more than one transcription initiation 152 
site so a single identity was chosen at random from the possible sites. This approach decreased 153 
discovery power, but was necessary to avoid bias that might be introduced into the identification 154 
based on a quantitative measure, such as abundance.  The 1,000 most significantly enriched named 155 
genes in the snatched and unsnatched sets are reported in Table S2.   156 
Host snRNA is targeted by the cap-snatching mechanism 157 
Key spliceosome snRNAs (RNU1, RNU11, RNU12, RNU4ATAC, RNU5A, RNU5E, RNU5F, RNU5D, RNU7) 158 
and their variants/pseudogenes were among the most significantly enriched named genes. This is 159 
consistent with previous observations that snRNAs are snatched frequently (5, 18) and shows that 160 
this may represent a true preference for these RNAs.  In view of this apparent preferential snatching 161 
of multiple snRNAs, we considered whether specific classes of capped host RNAs might be targeted.  162 
Of the RNA types considered, only snRNAs were strongly over-represented in the snatched 163 
population (Figure 3 A, B). It is unclear at this time if both mature snRNA (incorporated into the 164 
spliceosome) and immature snRNA (prior to nuclear export and processing) are snatched as leader 165 
sequences. 166 
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 9 
This sequencing method also allows the observation of histone mRNA which enabled us to observe 167 
that 10mers corresponding to histone mRNAs were also significantly over-represented.  168 
The 10mer corresponding to the transcript encoding the largest subunit of RNA polymerase II 169 
(POLR2A), was 5.83-fold over-represented in snatched sequences (OR = 5.83; FDR <0.05). PABPN1, 170 
which encodes poly(A) binding protein, was also over-represented (OR = 2.28; FDR <0.05). These 171 
comprise key elements of both transcription and polyadenylation of host mRNAs.  172 
Taken together these observations might imply that cap-snatching interferes with regulation of 173 
transcription and splicing in the infected cell.  However, POLR2B, another subunit of RNA polymerase 174 
II, was 7.77-fold under-represented (OR = 0.13; FDR < 0.05) making it difficult to draw simple 175 
conclusions from enrichment analysis that rely primarily on overlap statistics.  To rectify this, we 176 
performed further gene set enrichment analyses that take into account background gene expression 177 
to determine statistically over- and under-represented pathways affected by the cap-snatching 178 
mechanism.  179 
Specific ribosome-associated transcripts are avoided by the cap-snatching mechanism 180 
Identified transcripts from all time points and donors were collated and gene set enrichment analysis 181 
(FGSEA) performed by querying various pathway/gene ontology datasets (listed in Table S3). 182 
Querying Reactome identified a single over-represented pathway: RNA Polymerase II transcribes 183 
snRNA genes (Figure 3 C). A volcano plot highlighting the distribution of pathway members shows 184 
that many mRNA pathway members were under-represented and its enrichment as an over-185 
represented pathway was driven by snRNA transcripts (Figure 3 E), particularly snRNA members of 186 
the minor spliceosome. This is consistent with the observed apparent preferential snatching of 187 
snRNAs.  188 
Pathway enrichment also allowed us to look for pathways that were avoided by the cap-snatching 189 
mechanism.  We identified pathways associated with translation and ribosome formation as 190 
significantly under-represented in the cap-snatched pool (Figure 3 D).  Although multiple pathways 191 
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 10 
were identified, these were not independent: these associations were largely driven by presence of a 192 
group of transcripts encoding the same set of ribosomal proteins (Table S3).  These data show that 193 
IAV avoids snatching caps from ribosomal mRNA transcripts. Interestingly, not all mRNAs encoding 194 
ribosomal subunits were avoided. We compared our results to a recent study reporting the effect of 195 
targeted knockdown of specific ribosomal subunit mRNAs in the context of IAV infection (22), but saw 196 
no clear relationship between cap-snatching preference and viral protein production, host protein 197 
production, or antigen presentation.  198 
Enrichment of specific RNA motifs in the snatched and unsnatched sequence populations 199 
Leader sequences are known to commonly have ‘GCA’ at the interface between the host sequence 200 
and the IAV promoter (23, 24) introduced partially through the “prime and realign” mechanism (17, 201 
24, 25).  More recently, an ‘AG’ at the 5’ end of the leader sequence has also been shown to be 202 
prevalent in snatched sequences (6). 203 
Our analysis of 10mers enables a statistically powerful comparison of snatched and unsnatched 204 
sequences in which the position of sequence motifs can be compared without reference to distance 205 
from the 5’ or 3’ ends.  We used Pysster (26) to train convolutional neural networks using the 206 
sequence data to explore sequence and positional features, of a length of 4 nucleotides, for pools of 207 
highly-significantly over-represented snatched and unsnatched 10mers (0.3 >= OR >= 3, -log(FDR < 208 
10).  This stringency was introduced to eliminate potential noise. The snatched 10mers showed an 209 
enrichment of two motifs, A[G/C][T/A][C/G] and the similar sequence AGNN, both beginning at the 210 
first base (position 0) (Figure 4 A).  These motifs were most apparent 2 hours post infection, 211 
coinciding with levels of high transcription by the virus and are consistent with previous reports of an 212 
‘AG’ preference at the 5’ end of the leader (6). 213 
The unsnatched 10mers also showed an enrichment of two distinct motifs, CTAG and 214 
[T/C][A/T][T/G/A]A, most evident at 7 hours post infection (Figure 4 B).  While the CTAG motif was 215 
unsnatched primarily when it began in the first position (position 0), there was also an association 216 
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 11 
between this motif at any position in the 10mer and unsnatched status.  Similarly, the 217 
[T/C][A/T][T/G/A]A motif was avoided by cap snatching if it occurred at any position  218 
within the 10mer (Figure 4 B). To our knowledge this is the first evidence for the avoidance of 219 
particular sequences as priming leaders by the IAV polymerase. 220 
Network analysis of the response to IAV virus infection in MDM 221 
Temporal changes in host cell transcription are likely to occur both in recognition of viral infection 222 
and as a consequence of viral lifecycle progression. IAV can dysregulate host transcription, in a 223 
manner which leaves transcription initiation apparently unaffected (28). The advantage of CAGE in 224 
this scenario is the snapshot of transcription initiation it provides, in contrast to other technique, 225 
such as RNA-Seq which sequence the entire mRNA molecule, including downstream-of-gene 226 
transcripts (29). 227 
We utilised the network analytical tool, Graphia (30), to identify sets of co-regulated transcripts in the 228 
MDM response to IAV (Table S4).  For simplicity, we restricted the analysis to the dominant (most 229 
frequently used) promoters (p1) and used averaged data from the 4 donors.  We have summarised 230 
the GO term enrichment and pathway enrichment in the 10 largest clusters using GATHER 231 
(31)  (Table S5) and Enrichr (32, 33) (Table S6) respectively.   232 
Figure 5 A shows the sample-to-sample correlation graph for each of the averaged data sets.  233 
Although there was a global alteration in transcript induction that progressed with time, the profile at 234 
7 hours remained correlated with the profiles in uninfected cells at both early and late time points.  235 
This suggests that the virus did not cause a selective, or global, loss of host transcription initiation.  In 236 
keeping with that conclusion, the largest cluster, Cluster 1, contained more than 4,500 genes (Figure 237 
5 B) whose shared pattern was continuous induction across the time course with particularly high 238 
initiation at 24 hours.  This cluster contained genes encoding the interferon-responsive transcription  239 
factors, IRF1, 2, 4, 7, 8, and 9 and numerous known interferon-responsive antiviral effector genes 240 
(e.g. APOBEC3G, RSAD2, DDX58, ISG15, MX1, OAS1, TRIM25). 241 
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 12 
We observed that the response of MDMs to viral infection was immediate. IL1B was rapidly and 242 
strongly induced by IAV at 0 hours (effectively 1 hour post virus addition) and peaked at 2 hours  (3 243 
hours post virus addition) (Figure 5 C).  Other early response genes that were detected early after IAV 244 
exposure included those encoding immediate early transcription factors such as EGR1, the 245 
proinflammatory cytokine TNFα and the neutrophil chemoattractant CXCL2 (Figure 5 D-F).  246 
Rapidly-induced genes are concentrated in clusters 3 and 4, including interferons IFNB1, IFNA1, 247 
IFNA2, IFNA8, IFNA14, IFNE and further known IFN-regulated targets such as IFI6, IFIT2, 248 
IFITM3, IRG1, GBP1 and MNDA.  Also enriched in these clusters are genes involved in protein 249 
synthesis, including 46 ribosomal protein subunit genes, which are avoided by IAV cap-snatching (see 250 
above). 251 
Comparative analysis of the response of MDMs to treatment with IAV and with LPS 252 
The response of MDMs to IAV and LPS was compared at equivalent time points, uncovering some 253 
common transcripts that were induced in both treatments (Figure 5 H, top row).  Transcripts induced 254 
specifically by LPS but not by IAV were revealed by differential expression analysis (Figure 5 G, Table 255 
S7) and included classical inflammatory cytokines IL12B (although not IL12A) and IL6, and the 256 
feedback regulator of inflammation, IL10 (Figure 5 H, central row; Figure 6 A, B).  Conversely, 257 
induction of genes associated with interferon signalling was more substantial and prolonged in IAV-258 
treated MDM than those treated with LPS.  IAV induced IFNB1 mRNA some 10-fold more than 259 
observed in response to LPS in MDM, and sustained this expression throughout the time course 260 
(Figure 5 H, bottom row).  IAV also induced multiple IFNA genes (IFNA1, A2, A8, A14, A22, Figure 6 C-261 
E) and the type III interferon genes, IFNL1 (aka IL28A) and IFNL2 (aka IL29), which were not induced 262 
at all by LPS (Figure 5 H, bottom row; and Figure 6 F).   263 
264 
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 13 
Discussion 265 
This comprehensive analysis of host and viral transcripts reveals key features of the host-pathogen 266 
interaction at a molecular level. We demonstrate that IAV cap-snatching is biased towards host 267 
transcripts associated with splicing, and avoids host ribosomal subunit transcripts. Additionally, we 268 
provide a comprehensive analysis of transcripts initiated as part of the host response to IAV in a vital 269 
innate immune cell.  270 
Elimination of bias for accurate quantification of leader sequences and 5’ RNA ends 271 
Our choice of sequencing methodology and analytical approach eliminated numerous sources of bias 272 
that have limited the interpretation of previous studies of cap-snatching preference.   273 
The HeliScope single molecule CAGE sequencing methodology sequences transcripts from the 5’ end 274 
without internal segment-specific primers, and without PCR amplification (13).  In contrast, previous 275 
studies of IAV virus transcripts used internal primers for the viral segments (5, 8) or performed library 276 
amplification on cDNA derived from capped RNA (6).  A key difference from previous work is the 277 
quantification of background transcription, which enables the first accurate quantification of the 278 
transcripts not snatched by IAV. 279 
In addition, our use of terminal-depth sequencing limits noise and sampling error, in both the 280 
snatched sequences and the background distribution.  Since CAGE reads sequences directly from the 281 
5’ end, we can be confident that we have quantified the background pool of potential leader 282 
sequences that were available to be snatched.  By limiting our analysis to sequences of a specific 283 
length (10mers), we eliminate bias that may occur due to differential mapping or identification of 284 
sequences of different lengths. 285 
The cap-snatching mechanism is not entirely random  286 
Although random cap-snatching does occur, 18.8% of leaders are snatched multiple times and our 287 
analysis shows that many are snatched more frequently than one would expect from the level of 288 
background RNA expression. Non-coding RNAs, particularly snRNAs, have been identified as the 289 
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 14 
source of the most frequently snatched leader sequences (5, 6).  However, it was unclear whether 290 
this frequency reflected the high abundance of these transcripts in infected cells, or a true over-291 
representation of this RNA type among leaders.  Our analysis, enables an unbiased, accurate 292 
quantification of the abundance of each sequence in both the snatched, and unsnatched, sequence 293 
sets. 294 
Differential expression analysis revealed that all snRNAs, apart from RNU1, were upregulated in IAV-295 
treated MDMs compared to LPS (Table S7).  Notably, snRNA components of the minor spliceosome, 296 
(RNU11, RNU12, RNU4ATAC, RNU5A and RNU5E), a molecular machine that splices <1% of introns in 297 
the human genome, were highly snatched compared to background expression, particularly at 2 and 298 
7 hours. 299 
If cap-snatching were only determined by abundance, as previously thought (8, 9), we would expect 300 
to see leader sequences derived from ribosomal genes prominently among the snatched sequences.  301 
Our comparison of LPS and IAV-treated cells shows that genes encoding ribosomal subunits are highly 302 
transcribed in IAV-treated cells.  Although we do see a minority of mRNAs encoding ribosomal 303 
proteins in the snatched set, IAV cap-snatching exhibited a surprisingly strong avoidance of most 304 
mRNAs encoding ribosomal proteins, which is particularly evident in pathway enrichment analysis. 305 
Characteristics of MDM response to IAV 306 
The snapshot of transcription initiation provided by CAGE analysis allowed us to examine  307 
 co-expression clusters and observe the consistent similarity in global transcription initiation between 308 
uninfected and early post-infection time point MDMs, suggesting that most basic cellular processes 309 
are maintained during infection in this model.  The largest co-expression cluster, Cluster 1 (Table S4), 310 
included genes encoding the ubiquitin-proteasome complex, oxidative phosphorylation, cell cycle and 311 
transcriptional regulation including mRNA splicing and binding. In A549 cells, IAV infection causes cell 312 
cycle arrest (34), and down-regulation of cell-cycle associated genes.  Since MDM are not actively 313 
proliferative, the apparent induction by IAV infection of many cell cycle-related genes, including 314 
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cyclin genes and 19 genes encoding multiple cyclin-dependent kinases (CDK) is unlikely to be 315 
associated with cellular proliferation.   316 
The comparison between the host response in IAV and LPS treated MDMs 317 
Like LPS, IAV strongly induced TNF, IL1B, multiple chemokine genes (e.g. CCL2, CCL3, CXCL1, CXCL2, 318 
CCL20) and many genes for immediate early transcription factors (e.g. EGR family).  However, the 319 
global transcript initiation-based analysis of the response to IAV reveals a clear contrast to the LPS 320 
response in MDMs.  In LPS-treatment, levels of many inflammatory transcripts are subject to control 321 
by a complex network of rapidly-induced feedback regulators (10).  The sustained induction of 322 
proinflammatory transcripts in response to IAV contrasts with this transient induction in response to 323 
LPS.   324 
Following LPS treatment, MDM have low initiation of IL12A (p35) mRNA (Figure S 4 B), instead 325 
inducing IL23A and IL12B mRNA, which together encode the heterodimeric proinflammatory cytokine 326 
IL23.  These were not detected in IAV-infected cells.  Similarly, there was no detectable induction of 327 
the anti-inflammatory cytokine IL10 mRNA by IAV, while transcript initiation was massive and 328 
sustained in LPS treated cells.   329 
The type III interferons were specific to IAV-treated MDMs.  These were recently shown to mediate a 330 
key mechanism preventing viral spread to the lower respiratory tract in mice (35), which is believed 331 
to cause life-threatening disease in humans (36).  The profound difference in induction of IFN-332 
responsive genes in this cell type between LPS and IAV stimulation is reflective of blood 333 
transcriptome profiles of patients with severe IAV compared to those with bacterial sepsis (37). 334 
Limitations of this study 335 
Our study is to our knowledge the most comprehensive systems-level evaluation of both host and 336 
viral transcriptional activity for IAV replication, and the first study to perform an unbiased 337 
quantification of cap-snatching preference compared with accurate measurement of background 338 
transcription. It is, however, limited to a single cell type and one strain of IAV.  It is possible that the 339 
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observed apparent preference and avoidance of specific capped RNA are specific to MDMs. The 340 
observation that snRNAs RNU1 and RNU2 are the most frequently snatched sequences in H1N1 341 
infected A549 cells in other studies (17, 18), indicates that it is reasonable to speculate this 342 
mechanism is generalizable across other types.  Finally, our method measures total capped-RNA and 343 
does not differentiate between nuclear and cytoplasmic RNA molecules. 344 
Future work is needed to explore the mechanisms underlying the preference and avoidance of 345 
specific mRNAs, and to determine cap-snatching preferences of other IAV strains. 346 
  347 
 o
n
 M
arch 12, 2020 at UNIVERSITY O
F EDINBURG
H
http://jvi.asm.org/
D
ow
nloaded from
 
 17 
Materials and Methods 348 
Ethics, cell culture, virus propagation and infections 349 
Cells were isolated from fresh blood of volunteer donors under ethical approval from Lothian 350 
Research Ethics Committee (11/AL/0168).  Primary CD14+ human monocytes were isolated from 351 
whole blood as described previously (38) from 4 human donors.  Monocytes were plated for 7 days in 352 
RPMI-1640 supplemented with 10% (vol/vol) FBS, 2 mM glutamine, 100 U/ml penicillin, 100 μg/ml 353 
streptomycin (Sigma Co.), and 104 U/ml (100 ng/ml) recombinant human colony-stimulating factor 1 354 
(rhCSF1; a gift from Chiron, Emeryville, CA, USA) for differentiation into macrophages.  Cells were 355 
maintained at 37°C with 5% CO2.  A/Udorn/72 (H3N2) was generated as described previously (14).  356 
Differentiated macrophages were infected on day 8.  Cells were washed in serum free media after 357 
which they were infected at MOI 5 in a volume of 200μl infection media.  Cells were incubated for 1 358 
hour at 37°C then washed three times with serum-free media and incubated in RPMI-1640 359 
supplemented with 1μg/ml TPCK-trypsin, 0.7% BSA, 2mM glutamine, 100 U/ml penicillin, 100 μg/ml 360 
streptomycin (Sigma Co.), and 104 U/ml (100 ng/ml) rhCSF1.  Samples were collected at 4 time points 361 
post infection/media change: 0 hour (1 hour after addition of the virus), 2 hours, 7 hours and 24 362 
hours.  Uninfected samples were also collected at 0 and 24 hours.  LPS treatments were carried out 363 
as described previously (10).  Only time points with corresponding IAV treated time points were used 364 
in this analysis. 365 
Immunofluorescence 366 
Primary human monocyte derived macrophages were differentiated, as described above, on glass 367 
coverslips. Cells were infected as described. At 0, 2, 7, and 24 hours post infection cells were fixed for 368 
20 min in 4% formaldehyde in PBS. After permeabilisation with 0.2% Triton X124 100 in PBS for 5 min 369 
at room temperature, cells were incubated with mouse monoclonal influenza A NP AA5H (BioRad) at 370 
1:500. After 1 hour cells were washed three times with PBS 371 
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and incubated with goat anti-mouse Alexa Fluor 488 at 1:1000 (ThermoFisher). After 1 hour cells 372 
were washed three times with PBS and incubated in DAPI (ThermoFisher) for ten minutes after which 373 
they were washed three times with PBS and mounted on slides using VECTASHIELD® Antifade 374 
Mounting Medium. Cells were viewed on a Leica fluorescence upright microscope and imaged using a 375 
Hamamatsu Orca-ER low light mono camera. Scale bars were added using ImageJ. 376 
Cell viability and Virus Titration 377 
Cell viability was measured using Cell Titre Glo ® at 0, 2, 7, and 24 hours post infection. Virus 378 
produced was titrated by plaque assay on MDCK cells. Virus titres in cell supernatants were 379 
determined by plaque titration using ten-fold serial dilutions of virus stocks. Confluent MDCK cells in 380 
6 well plates were inoculated with cell supernatant for 1 hour in serum-free medium. An overlay 381 
(mixture of equal volume of DMEM and 2.4% Avicel (Sigma-Aldrich,UK) supplemented with 1 µg/ml 382 
TPCK-treated trypsin and 0.14% BSA fraction V) was then put onto the wells. After 48 hours, cells 383 
were fixed using 3.5% formaldehyde and stained with 0.1% crystal violet. Virus titres were calculated 384 
by (plaque count*dilution factor/(volume of inoculum)) and expressed as plaque forming units per 385 
millilitre of supernatant (pfu/ml). 386 
CAGE 387 
RNA was extracted using the Qiagen miRNeasy mini kit (217004).  RNA quality was assessed and 388 
CAGE was performed as described previously (39) as part of the FANTOM5 project.  Virus genome 389 
information is available in Table S8. 390 
Data analysis and identification of IAV mRNA 391 
Computational analysis was performed using custom Python scripts and as described previously (11). 392 
Capped IAV RNAs were identified by the conserved 11 base promoter sequence expected to be in all 393 
viral mRNA (‘GCAAAAGCAGG’), as described in the text. Sequences that contained the promoter were 394 
classified as capped viral mRNA and aligned to the Udorn sequence. 395 
Unbiased analysis of leader sequence preference 396 
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The first ten nucleotides of each CAGE tag (10mers) that reached the abundance threshold in our 397 
dataset were extracted and this set of unique 10mers were used in subsequent analysis.  The 398 
abundance threshold was set to 1,000 occurrences across all samples.  To determine the 10mer 399 
sequences that were over- and under-represented in the snatched population based on background 400 
abundance, the number of times a 10mer was associated with the IAV promoter was counted 401 
(“snatched”) along with the number of times the 10mer occurred without the promoter 402 
(“unsnatched”).  These were analysed using Fisher’s Exact test.  Benjamini-Hochberg correction was 403 
applied to p-values.  Significance was determined by an FDR < 0.05.  The number of times a 10mer 404 
was snatched was compared to the number of times it occurred unsnatched at the previous time 405 
point by Fisher’s Exact test. 406 
Assignment of transcript identity to 10mer sequences 407 
CAGE tags were mapped to the human reference genome (hg19) as described (11).  We extracted 408 
every possible chromosomal location for a 10mer that met the abundance threshold of 1000 across 409 
all samples from the original alignment BAMfiles created as part of the Fantom5 project. 10mers 410 
containing a 6mer from within the IAV promoter (‘GCAAAA’, ‘CAAAAG’, ‘AAAAGC’, ‘AAAGCA’, 411 
‘AAGCAG’, ‘AGCAGG’) were removed.  Reference transcription start sites were downloaded from 412 
Fantom5.  Promoter identity was assigned first using BEDtools 2.25.0 with a window of +/- 5 bases 413 
and exact strand match only.  For each possible promoter identity the 10mer sequence was mapped 414 
to the genomic sequence with a window of +/- 5 bases directly and exact matches only were used to 415 
assign promoter identity.   416 
A promoter identity was chosen at random from the list of mapped sites, to avoid any effect of 417 
abundance that may bias transcript identification.  Promoter identities were converted to HGNC 418 
format.  To determine preference of promoters and genes in leader sequences, all 10mers that were 419 
assigned to that promoter or gene name were counted and the Fisher’s Exact test was performed.  420 
Benjamini-Hochberg FDRs were calculated using the scipy.stats v 0.18.1 421 
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statsmodels.stats.multitest.mutlipletests function with method = ‘fdr_bh’.  Significance was 422 
determined by an FDR < 0.05.  RNA type was assigned to named transcripts using reference data 423 
downloaded from Biomart (http://www.ensembl.org).   424 
Pathway and Gene Set Enrichment Analysis 425 
GO term assignment and pathway analysis for coexpression clusters were performed using Enrichr 426 
(mp.pharm.mssm.edu/Enrichr) (32, 33) and GATHER (31).  Pathway databases queried were: 427 
Reactome 2016, KEGG 2016, WikiPathways 2016 and GO Molecular Function 2015, GO Cellular 428 
Component 2015 and GO Biological Process 2015.  Gene Set Enrichment analysis on ranked cap-429 
snatching preference data was performed using R package FGSEA (40), in R version 3.5.1, with the 430 
following parameters: set.seed = 42, min set size = 5, max size = 5000, nproc = 1, nperm = 1000000.  431 
Gene set libraries KEGG 2016, BioCarta 2016, Reactome 2016, WikiPathways 2016, NCI Nature 2016, 432 
GO Biological Process 2018, GO Molecular Function 2018, and GO Cellular Component 2018 were 433 
used.  Genes were ranked by -log10(p-value), and log10(OR).  Benjamini-Hochberg correction was 434 
applied to p-values. All named genes that appeared significant were included in this analysis. 435 
Analysis of leader motifs using convolutional neural networks 436 
A sub-set of 10mers that reached the following threshold: 0.3 < (OR) > 3, -log(FDR < 10) were brought 437 
forward for analysis of motif preference using convolutional neural networks. We optimised an 438 
existing network (26) for our use by using altering the parameters to find suitable settings. 439 
Optimisation experiments demonstrated that a kernel length of 4 gave us relatively high, and 440 
relatively consistent, precision and recall.   by using the grid search to explore various kernel lengths 441 
(2, 3, 4, and 5) and drop rate (0, 0.1, and 0.5);  for other parameters, we used the default settings of 442 
Pysster (kernel number: 20, convolutional layer number: 2) apart from learning rate at 0.0001 and 443 
patience, stopping at 100.  Since our analysis was restricted to 10mers, we did not use the pooling 444 
method.  We randomly selected the training set and validation set in the proportion of 60% and 30% 445 
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independently.  Motifs were considered if they reached a score of at least 50% the maximum score 446 
for that time point. 447 
Identification of potential alternative splice variants 448 
CAGE tags containing a leader sequence and an IAV promoter sequence followed by a sequence that 449 
did not align proximal to the IAV promoter sequence in the Udorn genome were extracted. These 450 
novel ‘promoter proximal’ sequences were hypothesised to be derived from putative 5’UTR 451 
sequences internal to a segment arising from mRNA from splice variants. These sequences were 452 
aligned throughout the Udorn genome using custom Python scripts. The abundance of each 453 
sequence was divided by the number of locations in the Udorn genome it could map to. The 454 
weighted abundances at each position were then summed and graphed. Segment 7 mRNA3 was used 455 
as a proof of principle 456 
Network Analysis of the MDM transcriptome during infection. 457 
Network analysis of the MDM transcriptome during infection was carried out using Graphia 458 
Professional (Kajeka Ltd., United Kingdom; http://www.kajeka.com) -formerly Biolayout Express3D.  459 
Results were filtered to exclude any transcript where the maximum value across all samples did not 460 
reach 10 tags per million (TPM).  The sample-to-sample analysis was performed at a Pearson 461 
correlation coefficient of ≥ 0.70.  The gene-to-gene analysis was performed at a Pearson correlation 462 
coefficient of ≥ 0.94 and used a relatively coarse Markov cluster algorithm inflation value of 1.7 to 463 
avoid excessive cluster fragmentation.  We restricted the analysis to the dominant promoters (p1) 464 
and used averaged data from the 4 donors. 465 
EdgeR analysis of LPS treated versus IAV treated samples. 466 
Differential expression between groups of genes was analysed using the EdgeR package (41) in R 467 
version 3.5.1.  CAGE data for LPS and IAV datasets were processed as described previously (10).  468 
Clustered transcription start site (CTSS) with a minimum expression level of 10 tags per million in at 469 
least one comparable time point, and with a coefficient of variation > 0.5, were included in 470 
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expression analysis.  Samples corresponding to 7 hours post-treatments were carried forward for 471 
analysis.  We used the glmFit function to fit the models and glmLRT to perform testing between the 472 
LPS and IAV treated samples.  Benjamini-Hochberg correction was applied to p-values.  A significance 473 
threshold of FDR < 0.05 was used. 474 
Data Availability 475 
Custom Python scripts are available at: https://github.com/baillielab/influenza_cage. 476 
CAGE data is available to download from http://fantom.gsc.riken.jp/5/data/. 477 
 478 
  479 
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Figure Legends 606 
Figure 1: Characterisation of human monocyte derived macrophages productively infected 607 
with IAV. 608 
(A) Experimental outline. Blood was taken from 4 human donors, with appropriate ethical approval. 609 
CD14+ monocytes were extracted using magnetic beads and cultured in CSF1 for 8-10 days. MDMs 610 
were infected with A/Udorn/72 (H3N2) at a multiplicity of infection of 5. At 4 time points (0, 2, 7, and 611 
24 hours after medium change) the cells were collected and RNA isolated. (B) Human MDMs were 612 
stained using antibodies specific for viral nucleoprotein to confirm infection at 0, 2, 7, and 24 hours 613 
post infection. Scale bars 10µm. (C) Viral titre was measured by plaque assay at 0, 2, 7, and 24 hours 614 
post infection (n = 3 independent experiments) and shown in pfu/ml supernatant. (D) Cell viability 615 
was measured using Cell Titre Glo™ at 0, 2, 7, and 24 hours post infection (n = 3 independent 616 
experiments). (E) Schematic showing the structure of the capped 5’ end of IAV mRNAs.  (F) Length of 617 
leader sequences across segments. Segments are coloured as shown in the legend. (G) Frequency, as 618 
percentage, of IAV promoter-containing CAGE tags in each IAV infected sample. 619 
 620 
Figure 2: IAV segment transcriptional dynamics during infection of MDM 621 
(A) The relative amount, compared to the total amount of viral mRNA, of mRNA from each viral 622 
segment was calculated for individual donors at each of the four timepoints. Height of the bar 623 
represents the mean frequency between donors. Error bars show standard deviation. (B) The 624 
positions of potential splice variant sequences aligned to the Udorn genome are shown as adjusted 625 
abundance (AA). The known mRNA3 splice variant in segment 7 is shown (blue arrow). Time points 626 
and donors have been collated to increase signal 627 
 628 
Figure 3. Pathways enrichment in snatched and unsnatched tenmer sequences.  629 
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(A, B) RNA type was assigned to 10mers based on transcript identity. Only 10mers with transcript 630 
identity were included. The significance of RNA type snatching was compared using ANOVA. RNA 631 
types were plotted against –log10(FDR) for 10mers of that type. The box denotes the interquartile 632 
range. The within the box represents the average and the whiskers represent standard deviation. The 633 
individual data-point for each 10mer is also plotted. The number of 10mers attributed to each RNA 634 
type is given as n above the box. (C) The 10 most under-represented pathways (negative enrichment 635 
score, blue) and single significantly over-represented pathway (positive enrichment score, orange) in 636 
the Reactome 2016 database are shown.  N represents the number of genes associated with that 637 
pathway detectable in the dataset.  p-values shown are Benjamini-Hochberg FDR-adjusted p-638 
values.  (D) Volcano plot showing the significance as -log10(FDR) and odds ratio of snatched versus 639 
unsnatched 10mers with members of the Reactome pathway ‘RNA Polymerase transcribes snRNA 640 
genes’ highlighted (snRNA, green diamonds, mRNA orange circles).  (E) The same volcano plot as in 641 
(D) with members of the Reactome pathway ‘Viral mRNA Translation’ highlighted (blue circles).  642 
 643 
Figure 4:  Nucleotide motifs associated with snatched and unsnatched tenmer sequences   644 
The first ten nucleotides of each CAGE tag were extracted and the abundance of each sequence 645 
associated with IAV was compared to the background abundance by Fisher’s Exact test (FDR < 646 
0.05).  Identification of motifs associated with snatched (A) and unsnatched (B) sequences.  Violin 647 
plots show the maximum activation distributions for snatched (S) and unsnatched (U) sequence 648 
categories in arbitrary units.  The four-nucleotide long motifs associated with each category are 649 
visualised as position weight matrices.  The positional enrichment of the four-nucleotide motifs 650 
across the 10mer sequences is shown.  The number of sequences is given as n above each bar 651 
chart. (C) Position weight matrices for all unsnatched sequences at each of four timepoints. 652 
 653 
  654 
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Figure 5.  Network analysis of the co-expressed genes during IAV infection in MDMs. 655 
(A) Sample-to-sample network.  A correlation coefficient of ≥ 0.7 was used to include all samples in 656 
the network.  Analysis was restricted to the dominant promoters (p1) and data were averaged across 657 
the 4 donors.  Blue – uninfected; pink – infected; darker colours show later time points.  (B) Gene-to-658 
gene correlation profile of transcripts.  Network analysis identified the sets of co-regulated 659 
transcripts in the MDM response to IAV.  Analysis was restricted to the dominant promoters (p1) and 660 
data were averaged across the 4 donors.  Lines represent connections at Pearson correlation 661 
coefficient ≥ 0.94 and spheres represent genes (promoters).  The clustering procedure used a 662 
relatively coarse Markov clustering algorithm of 1.7 to avoid excessive cluster fragmentation.  The 663 
four largest clusters, along with their average expression profiles, are shown.  Y axis in the expression 664 
profiles shows the expression level in tags per million (TPM).  (C-F) Abundance of transcripts for IL1B 665 
(C) EGR1 (D), TNFα (E) and CXCL2 (F) at the indicated time points.  y-axis shows expression in tags per 666 
million (TPM).  (G) Differential gene expression analysis comparing expression of transcripts in LPS- 667 
treated and IAV- treated monocyte derived MDMs.  Transcripts with a relative log fold change 668 
(log2FC) >=2 and a -log10(FDR) >=3 are shown in red (higher in LPS treated) and blue (higher in IAV 669 
infection).  Genes with greatest difference in expression are labelled.  Genes referenced in the text 670 
are shown in black.  (H) Comparison of the temporal response of genes between IAV- and LPS- 671 
treated MDMs.  Expression (TPM) of selected genes in LPS- treated (red) and IAV- infected (blue) 672 
human MDMs at 0, 2, 7, and 24 hours post treatment is shown in tags per million (TPM).  Solid lines 673 
show the mean expression of all donors (n = 3 for LPS, n = 4 for IAV).  Filled-in area shows standard 674 
deviation between donors.  675 
 676 
Figure 6: Comparative analysis of the response of MDMs to treatment with IAV and with LPS. 677 
(A-B) Comparison of the temporal response of transcripts between IAV- and LPS- treated MDMs. 678 
Relative expression of selected genes in LPS- treated (red) and IAV- infected (blue) human MDMs at 679 
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0, 2, 7, and 24 hours post treatment is shown in tags per million (TPM). Solid lines show the mean 680 
expression of all donors, filled-in area shows standard deviation between donors (n = 3 for LPS, n = 4 681 
for IAV).  682 
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